News

AbbVie raises 2025 revenue outlook to $60.5B as Skyrizi and Rinvoq drive growth

Discover AbbVie's standout Q2 2025 earnings insights, with strong Skyrizi & Rinvoq growth, raised revenue guidance, and robust R&D progress driving ...